NCT07783035

Brief Summary

The goal of this observational study is to evaluate the degree of compliance with the ABCDEF bundle and its relationship with clinical outcomes in adult patients (aged 18 and older) admitted to intensive care units (ICUs) in Latin America for at least 48 hours. The main questions it aims to answer are: What is the prevalence, cumulative incidence, and duration of delirium in adult ICU patients in Latin America? Is higher compliance with the ABCDEF bundle (low \[\<33%\], moderate \[33%-66%\], high \[\>66%\]) independently associated with a lower prevalence, cumulative incidence, and duration of delirium? Does higher ABCDEF bundle compliance improve functional mobility at hospital discharge and long-term cognitive, psychological, and quality-of-life outcomes at 3 and 6 months post-discharge? Researchers will compare three groups based on their level of ABCDEF bundle compliance (low \[\<33%\], moderate \[33%-66%\], and high \[\>66%\]) to see if higher bundle adherence improves delirium and long-term post-ICU functional outcomes. Participants will: Receive standard ICU care without experimental intervention. Undergo daily assessments for delirium (using CAM-ICU) and physical mobility (using ICU Mobility Scale) during their ICU stay. Complete telephone follow-up evaluations at 3 months post-discharge to assess cognitive function (BCAT-ICU/MoCA) and psychological symptoms (HADS, DSPS). Complete follow-up evaluations at 6 months post-discharge to assess cognitive function (full MoCA), psychological symptoms (HADS, DSPS), and health-related quality of life (EQ-5D-5L).

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
580

participants targeted

Target at P75+ for all trials

Timeline
3mo left

Started Aug 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress8%
Aug 2026Nov 2026

First Submitted

Initial submission to the registry

August 17, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 24, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

August 24, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 24, 2026

Expected
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

August 24, 2026

Status Verified

August 1, 2026

Enrollment Period

3 months

First QC Date

August 17, 2026

Last Update Submit

August 20, 2026

Conditions

Keywords

ABCDEF BundleDeliriumIntensive CarePost Intensive Care Syndrome

Outcome Measures

Primary Outcomes (3)

  • ICU Delirium Prevalence

    Percentage of adult patients experiencing delirium at any point during their ICU stay, evaluated daily using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU).

    Daily during the ICU stay (up to hospital discharge or a maximum of 30 days)

  • ICU Delirium Cumulative Incidence

    Percentage of patients without delirium at ICU admission who subsequently develop delirium during their ICU stay, assessed daily using the CAM-ICU.

    Daily during the ICU stay (up to hospital discharge or a maximum of 30 days).

  • ICU Delirium Duration

    Total number of days with delirium during the ICU stay, calculated from daily CAM-ICU assessments.

    Daily during the ICU stay (up to hospital discharge or a maximum of 30 days).

Secondary Outcomes (13)

  • Functional Mobility at ICU Discharge

    Assessed every 48 hours during the ICU stay until ICU discharge (up to 30 days)

  • Achievement of Standing or Walking at ICU Discharge

    Assessed every 48 hours during the ICU stay until ICU discharge (up to 30 days).

  • In-Hospital Mortality

    From ICU admission up to hospital discharge (approximately 30 days).

  • Post-ICU Cognitive Function at 3 Months

    3 months post-hospital discharge

  • Post-ICU Cognitive Function at 6 Months

    6 months post-hospital discharge.

  • +8 more secondary outcomes

Study Arms (3)

Low ABCDEF Bundle Compliance

Adult ICU patients who receive less than 33% of the ABCDEF bundle components (0 to 1 out of 6 components implemented) during their ICU stay.

Other: ABCDEF Bundle Compliance Assessment

Moderate ABCDEF Bundle Compliance

Adult ICU patients who receive between 33% and 66% of the ABCDEF bundle components (2 to 4 out of 6 components implemented) during their ICU stay.

Other: ABCDEF Bundle Compliance Assessment

High ABCDEF Bundle Compliance

Adult ICU patients who receive more than 66% of the ABCDEF bundle components (5 to 6 out of 6 components implemented) during their ICU stay.

Other: ABCDEF Bundle Compliance Assessment

Interventions

Observational assessment of routine ICU clinical care practices implementing the ABCDEF bundle components (A: Sedation Assessment, B: Spontaneous Breathing Trials, C: Choice of Anesthesia/Sedation, D: Delirium Assessment and Management, E: Early Mobility, F: Family Engagement). No experimental intervention is assigned by the study protocol.

High ABCDEF Bundle ComplianceLow ABCDEF Bundle ComplianceModerate ABCDEF Bundle Compliance

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult critically ill patients admitted to six multipurpose intensive care units across four Latin American countries (Colombia, Mexico, Chile, and Argentina) with an expected ICU stay of at least 48 hours

You may qualify if:

  • Age ≥18 years Admission to the ICU during the 3-month recruitment period
  • Expected ICU length of stay ≥48 hours
  • Written informed consent provided by the patient or legal representative (or eligibility for deferred consent according to local regulations)

You may not qualify if:

  • History of moderate to severe dementia
  • Severe chronic brain disease (e.g., previous disabling stroke, Parkinson's disease, advanced multiple sclerosis)
  • Severe prior intellectual disability or prior functional cognitive dependence
  • Palliative sedation scheduled from ICU admission
  • Deep irreversible coma or diagnosed brain death
  • Uncorrected bilateral deafness
  • Non-Spanish speakers
  • Refusal or explicit request by the family not to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

postintensive care syndromeCritical IllnessDelirium

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsNeurocognitive DisordersMental Disorders

Central Study Contacts

Job Heriberto Rodriguez Guillen

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 17, 2026

First Posted

August 24, 2026

Study Start

August 24, 2026

Primary Completion (Estimated)

November 24, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

August 24, 2026

Record last verified: 2026-08